Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Zuna

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Hemasphere|April 9, 2025
NGS-MRD negativity in post-HSCT ALL spares unnecessary therapeutic interventions triggered by borderline qPCR results without an increase in relapse riskKrystof Seferna, Michael Svaton, Andrea Rennerova, et al.
Leukemia|April 28, 2025
Somatic mutations and outcomes in chronic myeloid leukemia adolescent and young adults compared to children, adults, and BCR::ABL1-positive acute lymphoblastic leukemiaJitka Krizkova, Vaclava Polivkova, Adam Laznicka, et al.
Nature Communications|March 25, 2023
Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemiaEleanor L Woodward, Minjun Yang, Larissa H Moura-Castro, et al.
Haematologica|July 11, 2020
DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switchMichaela Novakova, Marketa Zaliova, Karel Fiser, et al.
British Journal of Haematology|February 26, 2016
Implications of delayed bone marrow aspirations at the end of treatment induction for risk stratification and outcome in children with acute lymphoblastic leukaemiaJan Zuna, Anja Moericke, Mari Arens, et al.
Blood|March 24, 2017
Monitoring of childhood ALL using <i>BCR-ABL1</i> genomic breakpoints identifies a subgroup with CML-like biologyLenka Hovorkova, Marketa Zaliova, Nicola C Venn, et al.
Science Translational Medicine|February 25, 2021
Functional reconstruction of human AML reveals stem cell origin and vulnerability of treatment-resistant MLL-rearranged leukemiaBernd B Zeisig, Tsz Kan Fung, Magdalena Zarowiecki, et al.
Haematologica|February 11, 2010
Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteriaEster Mejstrikova, Jana Volejnikova, Eva Fronkova, et al.
Casopis Lekaru Ceskych|May 22, 2015
[The prospects for children with acute lymphoblastic leukemia of being cured has increased in the Czech Republic in the 21st century to 90% - outcome of the ALL-IC BFM 2002 trial]Kateřina Zdráhalová, Jaroslav Štěrba, Jiří Domanský, et al.
Leukemia|May 31, 2020
Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remissionKaterina Machova Polakova, Hana Zizkova, Jan Zuna, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Hemasphere|April 9, 2025
NGS-MRD negativity in post-HSCT ALL spares unnecessary therapeutic interventions triggered by borderline qPCR results without an increase in relapse riskKrystof Seferna, Michael Svaton, Andrea Rennerova, et al.
Leukemia|April 28, 2025
Somatic mutations and outcomes in chronic myeloid leukemia adolescent and young adults compared to children, adults, and BCR::ABL1-positive acute lymphoblastic leukemiaJitka Krizkova, Vaclava Polivkova, Adam Laznicka, et al.
Nature Communications|March 25, 2023
Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemiaEleanor L Woodward, Minjun Yang, Larissa H Moura-Castro, et al.
Haematologica|July 11, 2020
DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switchMichaela Novakova, Marketa Zaliova, Karel Fiser, et al.
British Journal of Haematology|February 26, 2016
Implications of delayed bone marrow aspirations at the end of treatment induction for risk stratification and outcome in children with acute lymphoblastic leukaemiaJan Zuna, Anja Moericke, Mari Arens, et al.
Blood|March 24, 2017
Monitoring of childhood ALL using <i>BCR-ABL1</i> genomic breakpoints identifies a subgroup with CML-like biologyLenka Hovorkova, Marketa Zaliova, Nicola C Venn, et al.
Science Translational Medicine|February 25, 2021
Functional reconstruction of human AML reveals stem cell origin and vulnerability of treatment-resistant MLL-rearranged leukemiaBernd B Zeisig, Tsz Kan Fung, Magdalena Zarowiecki, et al.
Haematologica|February 11, 2010
Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteriaEster Mejstrikova, Jana Volejnikova, Eva Fronkova, et al.
Casopis Lekaru Ceskych|May 22, 2015
[The prospects for children with acute lymphoblastic leukemia of being cured has increased in the Czech Republic in the 21st century to 90% - outcome of the ALL-IC BFM 2002 trial]Kateřina Zdráhalová, Jaroslav Štěrba, Jiří Domanský, et al.
Leukemia|May 31, 2020
Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remissionKaterina Machova Polakova, Hana Zizkova, Jan Zuna, et al.
Pageof 5